Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group

Relapsed urothelial cancer represents an unmet medical need. Vinflunine is a third-generation antimicrotubuline inhibitor and is currently the only approved drug for second-line treatment across the European Union. We conducted a retrospective analysis assessing the efficacy and safety of vinflunine...

詳細記述

保存先:
書誌詳細
出版年:Anticancer Drugs
主要な著者: Pistamaltzian, Nikolaos, Tzannis, Kimon, Pissanidou, Vassiliki, Peroukidis, Stavros, Milaki, Georgia, Karavasilis, Vasilis, Mitsogiannis, Iraklis, Varkarakis, Ioannis, Papatsoris, Athanasios, Dellis, Athanasios, Adamakis, Ioannis, Stravodimos, Konstantinos, Molyva, Dimitra, Athanasiadis, Ilias, Androulakis, Nikos, Andreadis, Charalambos, Kalofonos, Charalambos, Mitropoulos, Dionisios, Deliveliotis, Charalambos, Constantinides, Constantinos, Dimopoulos, Meletios A., Bamias, Aristotelis
フォーマット: Artigo
言語:Inglês
出版事項: Lippincott Williams & Wilkins 2016
主題:
Clinical Reports
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4885529/
https://ncbi.nlm.nih.gov/pubmed/26421462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000297
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料